Effect of ω-conotoxin MVIIA and Phα1β on paclitaxel-induced acute and chronic pain

Pharmacology Biochemistry and Behavior

Volumn 114-115, Issue , 2013, Pages 16-22

  Rigo, Flávia K ^a,d   Dalmolin, Gerusa D ^b   Trevisan, Gabriela ^b   Tonello, Raquel ^b   Silva, Mariane A ^b   Rossato, Mateus F ^b   Klafke, Jonatas Z ^b   Cordeiro, Marta Do N ^c   Castro Junior, Célio J ^d   Montijo, Danuza ^d   Gomez, Marcus V ^a,d   Ferreira, Juliano ^a,b,e  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

^d Santa Casa de Belo Horizonte ^*  (Brazil)

^e FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Calcium channel blockers; Chemotherapy; Neuropathy; Peptide toxins; Phoneutria nigriventer

Indexed keywords

OMEGA CONOTOXIN; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DISEASE SEVERITY; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PHONEUTRIA NIGRIVENTER; PRIORITY JOURNAL; RAT;

ANIMALIA; PHONEUTRIA NIGRIVENTER; RATTUS;

CALCIUM CHANNEL BLOCKERS; CHEMOTHERAPY; NEUROPATHY; PEPTIDE TOXINS; PHONEUTRIA NIGRIVENTER;

ACUTE DISEASE; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; MALE; OMEGA-CONOTOXINS; PACLITAXEL; PAIN; RATS; RATS, WISTAR; SPIDER VENOMS;

EID: 84887277801     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.10.014     Document Type: Article

References (49)

1. S. Achim, L. Jörn, F. Rainer, and G. Gerd Ziconotide for treatment of severe chronic pain Lancet 375 2010 1569 1577
2. M. Arcos, J.M. Palanca, F. Montes, and C. Barrios Antioxidants and gabapentin prevent heat hypersensitivity in a neuropathic pain model J Invest Surg 26 2013 109 117
3. F. Ayuga-Loro, Á. Brocalero-Camacho, M.V. Quintas-López, and J.R. Cabrera-Feria Neuropsychiatric side effects of intrathecal ziconotide Rev Neurol 52 2011 61 63
4. C.J. Castro-Junior, J. Milano, A.H. Souza, J.F. Silva, F.K. Rigo, and G. Dalmolin Phα1β toxin prevents capsaicin-induced nociceptive behavior and mechanical hypersensitivity without acting on TRPV1 channels Neuropharmacology 71 2013 237 246
5. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh Quantitative assessment of tactile allodynia in the rat paw J Neurosci Methods 53 1994 55 63 (Pubitemid 24238751)
6. M. do N. Cordeiro, S.G. de Figueiredo, C. Valentim Ado, C.R. Diniz, V.R. von Eickstedt, and J. Gilroy Purification and amino acid sequences of six Tx3 type neurotoxins from the venom of the Brazilian 'armed' spider Phoneutria nigriventer (Keys) Toxicon 31 1993 35 42
7. G.D. Dalmolin, C.R. Silva, F.K. Rigo, G.M. Gomes, N. Cordeiro Mdo, and M. Richardson Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain Pain 152 2011 2224 2232
8. A.H. de Souza, M.C. Lima, C.C. Drewes, J.F. da Silva, K.C. Torres, and E.M. Pereira Antiallodynic effect and side effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer: Comparison with ω-conotoxin MVIIA and morphine Toxicon 58 2011 626 633
9. A.H. de Souza, C.J. Castro Jr., F.K. Rigo, S.M. de Oliveira, R.S. Gomez, and D.M. Diniz An evaluation of the antinociceptive effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer, and ω-conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain Cell Mol Neurobiol 33 2013 59 67
10. P.M. Dougherty, J.P. Cata, J.V. Cordella, A. Burton, and H.R. Weng Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients Pain 109 2004 132 142 (Pubitemid 38479779)
11. Z.P. Feng, C.J. Doering, R.J. Winkfein, A.M. Beedle, J.D. Spafford, and G.W. Zamponi Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA J Biol Chem 278 2003 20171 20178 (Pubitemid 36799212)
12. S.J. Flatters, and G.J. Bennett Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy Pain 109 2004 150 161 (Pubitemid 38479781)
13. P.A. Forsyth, C. Balmaceda, K. Peterson, A.D. Seidman, P. Brasher, and L.M. DeAngelis Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing J Neurooncol 35 1997 47 53 (Pubitemid 27361845)
14. J.A. Garrison, J.S. McCune, R.B. Livingston, H.M. Linden, J.R. Gralow, and G.K. Ellis Myalgias and arthralgias associated with paclitaxel Oncology 17 2003 271 277
15. A.N. Gordon, C.A. Stringer, C.M. Matthews, D.L. Willis, and J. Nemunaitis Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting J Clin Oncol 15 1997 1965 1973 (Pubitemid 27209527)
16. A. Holmes, R.S. Walters, R.L. Theriault, A.U. Buzdar, D.K. Frye, and G.N. Hortobagyi Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer J Natl Cancer Inst 83 1991 1797 1805
17. K. Kawakami, T. Chiba, N. Katagiri, M. Saduka, K. Abe, and I. Utsunomiya Paclitaxel increases high voltage-dependent calcium channel current in dorsal root ganglion neurons of the rat J Pharmacol Sci 120 2012 187 195
18. R. Kristipati, L. Nadasdi, K. Tarczy-Hornoch, K. Lau, G.P. Miljanich, and J. Ramachandran Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels Mol Cell Neurosci 5 1994 219 228 (Pubitemid 24172504)
19. A. Kukkar, A. Bali, N. Singh, and A.S. Jaggi Implications and mechanism of action of gabapentin in neuropathic pain Arch Pharm Res 36 2013 237 251
20. C.L. Loprinzi, K. Maddocks-Christianson, S.L. Wolf, R.D. Rao, P.J. Dyck, and P. Mantyh The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism Cancer J 13 2007 399 403
21. C.L. Loprinzi, B.N. Reeves, S.R. Dakhil, J.A. Sloan, S.L. Wolf, and K.N. Burger Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1 J Clin Oncol 29 2011 1472 1478
22. C. Maier, H.H. Gockel, K. Gruhn, E.K. Krumova, and M.A. Edel Increased risk of suicide under intrathecal ziconotide treatment? - A warning Pain 152 2011 235 237
23. A.B. Malmberg, and T.L. Yaksh Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception J Neurosci 14 1994 4882 4890 (Pubitemid 24237910)
24. M. Naguib, J.J. Xu, P. Diaz, D.L. Brown, D. Cogdell, and B. Bie Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system Anesth Analg 114 2012 1104 1120
25. R.D. Penn, and J.A. Paice Adverse effects associated with the intrathecal administration of ziconotide Pain 85 2000 291 296 (Pubitemid 30110772)
26. D. Perret, and Z.D. Luo Targeting voltage-gated calcium channels for neuropathic pain management Neurotherapeutics 6 2009 679 692
27. A.D. Piekarz, M.R. Due, M. Khanna, B. Wang, M.S. Ripsch, and R. Wang CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy Mol Pain 24 8 2012 54
28. R.C. Polomano, and G.J. Bennett Chemotherapy-evoked painful peripheral neuropathy Pain Med 2 2001 8 14 (Pubitemid 32447626)
29. R.C. Polomano, A.J. Mannes, U.S. Clark, and G.J. Bennett A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel Pain 94 2001 293 304 (Pubitemid 33145399)
30. E. Prommer Ziconotide: a new option for refractory pain Drugs Today (Barc) 42 2006 369 378 (Pubitemid 44090111)
31. R.L. Rauck, M.S. Wallace, A.W. Burton, L. Kapural, and J.M. North Intrathecal ziconotide for neuropathic pain: a review Pain Pract 9 2009 327 337
32. B.N. Reeves, S.R. Dakhil, J.A. Sloan, S.L. Wolf, K.N. Burger, and A. Kamal Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1 Cancer 118 2012 5171 5178
33. F.K. Rigo, G. Trevisan, F. Rosa, G.D. Dalmolin, M.F. Otuki, and A.P. Cueto Spider peptide Phα1β induces analgesic effect in a model of cancer pain Cancer Sci 29 2013 1 5
34. E.K. Rowinsky, E.A. Eisenhauer, V. Chaudhry, S.G. Arbuck, and R.C. Donehower Clinical toxicities encountered by paclitaxel (Taxol) Semin Oncol 20 1993 1 15 (Pubitemid 23239390)
35. M.W. Saif, and S. Hashmi Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer Cancer Chemother Pharmacol 61 2008 349 354 (Pubitemid 350275990)
36. C. Siau, W. Xiao, and G.J. Bennett Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells Exp Neurol 201 2006 507 514 (Pubitemid 44344243)
37. M.T. Smith, P.J. Cabot, F.B. Ross, A.D. Robertson, and R.J. Lewis The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices Pain 96 2002 119 127 (Pubitemid 34270634)
38. T.P. Snutch Targeting chronic and neuropathic pain: the N-type calcium channel comes of age NeuroRx 2 2005 662 670 (Pubitemid 41393273)
39. A.H. Souza, J. Ferreira, N. Cordeiro Mdo, L.B. Vieira, C.J. De Castro, and G. Trevisan Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom Pain 140 2008 115 126
40. P.S. Staats, T. Yearwood, S.G. Charapata, R.W. Presley, M.S. Wallace, and M. Byas-Smith Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial J Am Med Assoc 291 2004 63 70 (Pubitemid 38040536)
41. 2 + channels J Neurosci 17 1997 3002 3013 (Pubitemid 27175814)
42. L.B. Vieira, C. Kushmerick, M.E. Hildebrand, E. Garcia, A. Stea, and M.N. Cordeiro Inhibition of high voltage-activated calcium channels by spider toxin p nTx3-6 J Pharmacol Exp Ther 314 2005 1370 1377 (Pubitemid 41206004)
43. Y.X. Wang, S. Bezprozvannaya, S.S. Bowersox, L. Nadasdi, G. Miljanich, and G. Mezo Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers Naunyn Schmiedebergs Arch Pharmacol 357 1998 159 168 (Pubitemid 28085516)
44. C. Wasserheit, A. Frazein, R. Oratz, J. Sorich, A. Downey, and H. Hochster Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity J Clin Oncol 14 1996 1993 1999 (Pubitemid 26230099)
45. R.J. Winquist, J.Q. Pan, and V.K. Gribkoff Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain Biochem Pharmacol 70 2005 489 499 (Pubitemid 40978538)
46. S. Woolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies Eur J Cancer 44 2008 1507 1515
47. W. Xiao, A. Boroujerdi, G.J. Bennett, and Z.D. Luo Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit Neuroscience 144 2007 714 720 (Pubitemid 44856756)
48. G.W. Zamponi, R.J. Lewis, S.M. Todorovic, S.P. Arneric, and T.P. Snutch Role of voltage-gated calcium channels in ascending pain pathways Brain Res Rev 60 2009 84 89
49. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110 (Pubitemid 13058546)